25 June 2017 - This cancer drug produced data so incredible that the FDA approved it immediately for a specific genetic mutation, regardless of cancer location.
The U.S. FDA is tasked with an inglorious job. It digs through hundreds, if not thousands, of pages of clinical trial data to determine if an experimental drug or medical device effectively reaches its treatment goal without outweighing the risks involved with taking or using it. The FDA has formally done this task for the past 111 years, although its more informal origins can be traced all the way back to 1848.